What corticosteroid medication can be prescribed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 5, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Corticosteroid Medications Available for Prescription

Multiple corticosteroid formulations are available for prescription, with selection based on route of administration, potency requirements, and specific clinical indication.

Systemic (Oral) Corticosteroids

Most Commonly Prescribed Oral Agents

  • Prednisone is available in tablets of 1,2.5,10,20, and 50 mg, and as liquid formulations (5 mg/cc, 5 mg/5 cc) 1
  • Prednisolone is available in similar formulations and is the preferred oral corticosteroid in many guidelines, with typical dosing ranging from 0.25-2 mg/kg daily depending on indication 1
  • Methylprednisolone can be prescribed at doses of 0.25-2 mg/kg daily for oral use 1

Alternative Oral Corticosteroids

  • Dexamethasone is a potent, long-acting corticosteroid that can be used orally, though it should generally be avoided for routine replacement therapy due to its long half-life 1
  • Hydrocortisone (15-25 mg daily in divided doses) is the preferred agent for adrenal replacement therapy, typically given as 10+5+2.5 mg or 15+5+5 mg in three divided doses 1
  • Cortisone acetate (25-37.5 mg daily) is an alternative for replacement therapy, given in divided doses such as 12.5+6.25+6.25 mg 1

Inhaled Corticosteroids (ICS)

  • Multiple ICS formulations are available for asthma management and represent the most consistently effective long-term control medication for persistent asthma 1
  • Fluticasone/salmeterol combination (Advair) is available for once or twice-daily dosing 1
  • Budesonide MMX and beclomethasone dipropionate are topically-acting oral corticosteroids that can be used for inflammatory bowel disease as alternatives to systemic steroids 1

Topical Corticosteroids

  • Hydrocortisone hemisuccinate, triamcinolone in Orabase 0.1%, and betamethasone valerate 0.1 mg are available for oral mucosal diseases 2
  • Clobetasol propionate 0.05% cream is a high-potency topical corticosteroid for dermatologic conditions 1
  • Intranasal corticosteroids are recommended for allergic rhinitis and sinusitis in asthma patients 1

Injectable Corticosteroids

Intravenous Formulations

  • Methylprednisolone can be given intravenously at doses of 10-20 mg/kg (250-1000 mg) for pulse therapy in severe conditions 1
  • Hydrocortisone is available for IV administration, particularly recommended at <400 mg/day for septic shock 1

Intramuscular Formulations

  • Methylprednisolone 120 mg intramuscular injection can be used every 3 weeks as an alternative to oral therapy in specific conditions 1

Dosing Considerations by Indication

Acute Severe Conditions

  • Prednisolone 40-60 mg daily (or equivalent) is recommended for moderate to severe ulcerative colitis, tapered over 6-8 weeks 1
  • Prednisone 40-60 mg daily for 3-10 days as a short-course burst for asthma exacerbations 1
  • Methylprednisolone 20-40 mg/day (or equivalent) for up to 10 days in COVID-19 pneumonia with respiratory failure 3

Chronic Maintenance Therapy

  • Prednisolone 4-5 mg daily in one or two divided doses may be used for select patients requiring long-term therapy, though this should be minimized whenever possible 1
  • Hydrocortisone 15-25 mg daily in divided doses (typically three times daily) for primary adrenal insufficiency 1

Important Safety Considerations

  • Short-term use (less than 2 weeks) of oral corticosteroids at doses up to 40-60 mg prednisolone equivalent can cause reversible adverse effects including glucose intolerance, fluid retention, mood changes, and hypertension 1
  • Long-term use carries risks of adrenal suppression, growth suppression in children, osteoporosis, diabetes, cataracts, and immunosuppression 1
  • Doses above 40-60 mg/day prednisolone equivalent do not provide additional benefit and increase adverse effects 1
  • Osteoporosis prophylaxis must be considered at the outset of systemic corticosteroid treatment 1
  • Gastroprotection with proton-pump inhibitors should be added when starting corticosteroid therapy 4

References

1
Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

2
Research

Corticosteroids in diseases of the oral mucosa.

International dental journal, 1976

4
Guideline

Corticosteroid Management for Severe Gastrointestinal Manifestations in Henoch‑Schönlein Purpura

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

Which medication reduces preload by decreasing venous return?
Should I stop taking this medication without consulting my prescriber?
Is bleeding from the genital area of a 4‑day‑old newborn normal?
What is the likely diagnosis linking persistent headaches, generalized hypotonia, unexplained weight loss, polydipsia, polyuria, increased bowel frequency, brain fog, anxiety, arrhythmia, diffuse muscle weakness, new‑onset hirsutism, recurrent otitis and gastroenteritis, and a childhood acute myositis episode in a 29‑year‑old male?
In an 18-year-old female who experienced bleeding and pain after a vaginal swab performed yesterday, should these symptoms be expected to be self‑limiting?
In a patient with limited life expectancy who is on an antidepressant (e.g., sertraline 50 mg daily), should the medication be continued, tapered, or discontinued?
How should I manage a 62‑year‑old male with hypothyroidism and metabolic syndrome who has subclinical hypothyroidism (TSH 4.86 mIU/L, normal free T4) and a low serum creatinine (0.61 mg/dL) with a high BUN/creatinine ratio but normal eGFR?
Is it appropriate to continue my current lipid‑lowering regimen of inclisiran (Leqvio) 284 mg every six months plus a high‑intensity 80 mg statin after coronary artery stenting, given a low‑density lipoprotein cholesterol of 21 mg/dL and total cholesterol of 91 mg/dL?
How should I manage a patient currently taking warfarin (Coumadin) 2.5 mg daily, including INR monitoring and dose adjustments?
Can sugammadex be used safely to reverse aminosteroid neuromuscular blockade in patients with demyelinating polyneuropathy (e.g., Guillain‑Barré syndrome or multiple sclerosis)?
What evaluation and management is recommended for a 21-year-old male with bilateral knee pain that occurs primarily at night and in the morning when it is cold, but not during the day?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question